Seifried E - Search Results

1

Thrombolysis using consecutive high dose bolus and infusion of alteplase in a patient with acute massive pulmonary embolism.

Tebbe U, Seifried E, Carlsson J, Tanswell P. Tebbe U, et al. Among authors: seifried e. Blood Coagul Fibrinolysis. 1992 Aug;3(4):475-80. Blood Coagul Fibrinolysis. 1992. PMID: 1420824

2

Influence of acute myocardial infarction and rt-PA therapy on circulating fibrinogen.

Seifried E, Oethinger M, Tanswell P, Hoegee-de Nobel E, Nieuwenhuizen W. Seifried E, et al. Thromb Haemost. 1993 Apr 1;69(4):321-7. Thromb Haemost. 1993. PMID: 8497843

3

Studies on the functionality of fibrinogen during rt-PA therapy: results of three different methods of fibrinogen determination.

Seifried E, Oethinger M, Tanswell P, Hoegee-de Nobel H, Nieuwenhuizen W. Seifried E, et al. Blood Coagul Fibrinolysis. 1992 Feb;3(1):81-7. doi: 10.1097/00001721-199202000-00012. Blood Coagul Fibrinolysis. 1992. PMID: 1623123

4

Single-bolus injection of recombinant tissue-type plasminogen activator in acute myocardial infarction.

Tebbe U, Tanswell P, Seifried E, Feuerer W, Scholz KH, Herrmann KS. Tebbe U, et al. Among authors: seifried e. Am J Cardiol. 1989 Sep 1;64(8):448-53. doi: 10.1016/0002-9149(89)90419-0. Am J Cardiol. 1989. PMID: 2505604

5

Pharmacokinetics and haemostatic status during consecutive infusions of recombinant tissue-type plasminogen activator in patients with acute myocardial infarction.

Seifried E, Tanswell P, Ellbrück D, Haerer W, Schmidt A. Seifried E, et al. Thromb Haemost. 1989 Jun 30;61(3):497-501. Thromb Haemost. 1989. PMID: 2508258

6

Current developments in thrombolytic therapy using novel plasminogen activators.

Seifried E, Tanswell P. Seifried E, et al. Arzneimittelforschung. 1989 Nov;39(11):1474-82. Arzneimittelforschung. 1989. PMID: 2695093 Review.

7

Effect of reteplase on hemostasis variables: analysis of fibrin specificity, relation to bleeding complications and coronary patency.

Meierhenrich R, Carlsson J, Seifried E, Pfarr E, Smolarz A, Neuhaus KL, Tebbe U. Meierhenrich R, et al. Among authors: seifried e. Int J Cardiol. 1998 Jun 1;65(1):57-63. doi: 10.1016/s0167-5273(98)00100-4. Int J Cardiol. 1998. PMID: 9699932 Clinical Trial.

8

Pharmacokinetics and fibrin specificity of alteplase during accelerated infusions in acute myocardial infarction.

Tanswell P, Tebbe U, Neuhaus KL, Gläsle-Schwarz L, Wojcik J, Seifried E. Tanswell P, et al. Among authors: seifried e. J Am Coll Cardiol. 1992 Apr;19(5):1071-5. doi: 10.1016/0735-1097(92)90297-z. J Am Coll Cardiol. 1992. PMID: 1372625 Free article.

9

Pharmacokinetics and hepatic catabolism of tissue-type plasminogen activator.

Tanswell P, Seifried E, Stang E, Krause J. Tanswell P, et al. Among authors: seifried e. Arzneimittelforschung. 1991 Dec;41(12):1310-9. Arzneimittelforschung. 1991. PMID: 1815534 Review.

10

Comparison of specific antibody, D-Phe-Pro-Arg-CH2Cl and aprotinin for prevention of in vitro effects of recombinant tissue-type plasminogen activator on haemostasis parameters.

Seifried E, Tanswell P. Seifried E, et al. Thromb Haemost. 1987 Oct 28;58(3):921-6. Thromb Haemost. 1987. PMID: 2448890

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

377 results

Search Page

Filters